Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
3,514,581
-
Shares change
-
-89,925
-
Total reported value, excl. options
-
$17,683,000
-
Value change
-
-$293,543
-
Number of buys
-
19
-
Number of sells
-
13
-
Price
-
$5.03
Institutional Holders of InflaRx N.V. - COM (IFRX) as of Q4 2020
As of 31 Dec 2020 InflaRx N.V. - COM (IFRX) had 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,514,581 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, MORGAN STANLEY, ORBIMED ADVISORS LLC, FNY Investment Advisers, LLC, Bank Julius Baer & Co. Ltd, Zurich, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, Verition Fund Management LLC, Birchview Capital, LP, and SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC.
This table shows 41 institutional shareholders of the security as of 31 Dec 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.